Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
Actual shortage: | 249 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-11-28 | 2022-08-18 | 99935 |
TEVA-LEVOCARBIDOPA | 25MG 100MG | TABLET | Actual shortage | 2019-12-05 | 2022-08-18 | 100299 |
TEVA-LEVOCARBIDOPA | 25MG 250MG | TABLET | Actual shortage | 2020-02-21 | 2020-03-26 | 106945 |
TEVA-LEVOCARBIDOPA | 10MG 100MG | TABLET | Actual shortage | 2020-03-26 | 2020-03-26 | 109550 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-02-25 | 2021-04-08 | 134727 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153132 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-08 | 2023-08-18 | 194103 |
TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-08 | 2023-10-04 | 194106 |
TEVA-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-06-19 | 2023-10-04 | 195484 |
TEVA-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195591 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-08-21 | 2017-09-19 | 19968 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2020-02-07 | 2021-04-01 | 105590 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-02-02 | 2023-10-06 | 183404 |
TEVA-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195833 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2019-12-12 | 2020-01-25 | 101145 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-06-25 | 2020-07-23 | 118928 |
TEVA-LENOLTEC NO. 4 | 300MG 60MG | TABLET | Resolved | 2020-10-01 | 2020-10-22 | 125458 |
TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153724 |
TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2022-03-24 | 2022-05-05 | 157259 |
TEVA-LENOLTEC NO. 4 | 60MG 300MG | TABLET | Resolved | 2023-10-05 | 2024-01-19 | 206374 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |